Dr. David Callaway Lopresti, MD

Dr. Lopresti practices at Memorial Medical Center in Las Cruces, New Mexico, part of Lifepoint Health.

Dr. Lopresti's NPI, 1609842517, was assigned on February 28, 2006. Dr. Lopresti holds Arizona license 43233.

Dr. Lopresti's primary practice is Memorial Medical Center, at 2450 South Telshor Blvd, Las Cruces, NM 88011 in Dona Ana County. The practice phone is (575) 522-8641.

Dr. Lopresti's primary practice is Memorial Medical Center in Las Cruces, New Mexico, part of Lifepoint Health. Dr. Lopresti is also affiliated with TriStar Centennial Medical Center. The medical group on file is Sonoran Radiology. Dmand AI also links Dr. Lopresti to 3 more hospitals, 5 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lopresti practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Lopresti's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Lopresti is licensed in Arizona.

CMS data shows 158 Medicare services from Dr. Lopresti across 6 procedure codes in 2024, for 145 Medicare patients. Medicare paid $8,373 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 145 Medicare patients who saw Dr. Lopresti in 2024. The largest group is 75 to 84, with 69 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lopresti's median patient age at 69, with 56% women.

In 2022, Dr. Lopresti wrote 38 Medicare Part D claims. They cover 2 drugs, with $19,958 in total drug cost. In 2021, CMS named 44 claims across 1 drug.

Dr. Lopresti accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 210 general payments to Dr. Lopresti from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 69% of the total. Abbott Laboratories paid the most, $2,661.